NCT00030823View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH conjugate vaccine

BIOLOGICAL

QS21

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00030823 - Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence | Biotech Hunter | Biotech Hunter